An RVC Biofund portfolio company will create a Research Center on the Sirius site

National BioService, an RVC Biofund portfolio company and resident of Skolkovo Technopark, was admitted to the Sirius Innovative Science and Technology Center (Sirius ISTC). The company plans to create a Center for Preclinical and Translational Research on the Sirius ISTC site.

National BioService combines the competencies of a biobank and bioservice. The company develops innovative drugs and diagnostic systems in partnership with leading domestic pharmaceutical companies.

This work is impossible without creating technological infrastructure for biobanking, which ensures uniform standards for the collection, processing, transportation, storage and labeling of biomaterials. The services to be offered at the future Center for Preclinical and Translational Research will be available not only to Sirius ISTC residents, but also to Russian and foreign pharmaceutical and diagnostic companies.